Geographic Variation in the Prevalence of High-Risk Medication Use Among Medicare Part D Beneficiaries by Hospital Referral Region

被引:1
|
作者
Chinthammit, Chanadda [1 ,2 ]
Bhattacharjee, Sandipan [3 ]
Axon, David R. [3 ]
Slack, Marion [3 ]
Bentley, John P. [4 ]
Warholak, Terri L. [3 ]
Wilson, Debbie L. [5 ]
Lo-Ciganic, Wei-Hsuan [5 ,6 ]
机构
[1] Univ Arizona, Coll Pharm, Dept Pharmaceut Sci, Tucson, AZ 85721 USA
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA
[4] Univ Mississippi, Sch Pharm, Dept Pharm Adm, University, MS 38677 USA
[5] Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, POB 100496,1225 Ctr Dr,HPNP Bldg,Rm 3338, Gainesville, FL 32610 USA
[6] Univ Florida, Coll Pharm, Ctr Drug Evaluat & Safety, Gainesville, FL 32610 USA
来源
关键词
POTENTIALLY INAPPROPRIATE MEDICATION; ELDERLY-PATIENTS; BEERS CRITERIA; STAR RATINGS; OLDER-ADULTS; CARE; PHARMACY; QUALITY; IMPACT;
D O I
10.18553/jmcp.2020.26.10.1309
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BACKGROUND: Understanding geographic patterns of high-risk medication (HRM) prescribed and dispensed among older adults may help the Centers for Medicare & Medicaid Services and their partners develop and tailor prevention strategies. OBJECTIVE: To compare the geographic variation in the prevalence of HRM use among Medicare Part D beneficiaries from 2011 to 2013, for Medicare Advantage Prescription Drug (MA-PD) plans and stand-alone Prescription Drug Plans (PDPs). METHODS: This retrospective study used the data of a 5% national Medicare sample (2011-2013). Beneficiaries were included in the study if they were aged >= 65 years, continuously enrolled in MA-PDs or PDPs (similar to 1.3 million each year), and had 2 prescriptions for the same HRM (e.g., amitriptyline) prescribed and dispensed during the year based on the Pharmacy Quality Alliance's (PQA) quality measures for HRM use. Multivariable logistic regression was used to estimate adjusted annual HRM use rates (i.e., adjusted predictions, average marginal predictions, or model-adjusted risk) across 306 Dartmouth Atlas of Health Care hospital referral regions (HRRs), controlling for sociodemographic, health-status, and access-to-care factors. RESULTS: Among eligible beneficiaries each year (1,161,076 in 2011, 1,237,653 in 2012, and 1,402,861 in 2013), nearly 40% were enrolled in MA-PD plans, whereas the remaining 60% were in PDP plans. The adjusted prevalence of HRM use significantly decreased among Medicare beneficiaries enrolled in MA-PD (13.1%-8.4%, P<0.001) and PDP (16.2%-12.2%, P<0.001) plans from 2011 to 2013. For MA-PD and PDP beneficiaries, HRM users were more likely to be (all P<0.001) the following: female (MA-PD: 70.4% vs. 59.9%; PDP: 72.8% vs. 62.5%); White (MA-PD: 84.6% vs. 81.4%; PDP: 86.6% vs. 85.3%); with low-income subsidy or dual eligibility for Medicaid (MA-PD: 22.3% vs. 16.6%; PDP: 29.2% vs. 23.3%); and disabled (MA-PD: 15.6% vs. 8.7%; PDP: 15.4% vs. 8.5%) compared with non-HRM users in 2013. In 2013, significant geographic variation existed, with the ratios of 75th-25th percentiles of HRM use rates across HRRs as 1.42 for MA-PDs and 1.31 for PDPs. For MA-PDs, the top 5 HRRs with the highest HRM use rates in 2013 were Casper, WY (20.4%), Waco, TX (16.7%), Lubbock, TX (15.7%), Santa Barbara, CA (15.2%), and Temple, TX (15.1%); for PDP5, they were Lawton, OK (18.8%), Alexandria, LA (18.8%), Lake Charles, LA (18.6%), Oklahoma City, OK (18.0%), and Slidell, LA (18.0%). CONCLUSIONS: Substantial geographic variation exists in the prevalence of HRM use among older adults in Medicare, regardless of prescription drug plan. Areas with high prevalence of HRM use may benefit from targeted interventions (e.g., medication therapy management monitoring or alternative medication substitutions) to prevent potential adverse consequences. Copyright (C) 2020, Academy of Managed Care Pharmacy. All rights reserved.
引用
收藏
页码:1309 / 1316
页数:8
相关论文
共 50 条
  • [1] GEOGRAPHIC VARIATION OF HIGH-RISK MEDICATION USE AMONG MEDICARE BENEFICIARIES IN THE UNITED STATES
    Chinthammit, C.
    Bhattacharjee, S.
    Slack, M.
    Bentley, J. P.
    Warholak, T.
    Lo-Ciganic, W.
    [J]. VALUE IN HEALTH, 2018, 21 : S45 - S46
  • [2] HEALTH PLAN PERFORMANCE ON HIGH-RISK MEDICATION USE AMONG MEDICARE PART D BENEFICIARIES: IMPACT OF RISK ADJUSTMENT
    Chinthammit, C.
    Axon, D.
    Bhattacharjee, S.
    Slack, M.
    Lo-Ciganic, W.
    Bentley, J. P.
    Warholak, T.
    [J]. VALUE IN HEALTH, 2020, 23 : S304 - S304
  • [3] ASSOCIATION OF LOW-INCOME SUBSIDY/DUAL ELIGIBILITY AND DISABILITY WITH HIGH-RISK MEDICATION USE AMONG PART D MEDICARE BENEFICIARIES
    Chinthammit, C.
    Bhattacharjee, S.
    Slack, M.
    Lo-Ciganic, W.
    Bentley, J. P.
    Axon, D.
    Warholak, T.
    [J]. VALUE IN HEALTH, 2020, 23 : S303 - S303
  • [4] GEOGRAPHIC VARIATION OF HIGH-RISK OPIOID USE AND RISK OF OVERDOSE AMONG DISABLED MEDICARE BENEFICIARIES IN THE US FROM 2011 TO 2015
    Lo-Ciganic, W.
    Gellad, W. F.
    Zhou, L.
    Donohue, J. M.
    Roubal, A.
    Hines, M.
    Lindermann, J.
    Malone, D. C.
    Bhattacharjee, S.
    Lee, J. K.
    Kwoh, C. K.
    [J]. VALUE IN HEALTH, 2018, 21 : S2 - S2
  • [5] GEOGRAPHIC VARIATION OF HIGH-RISK PRESCRIPTION OPIOID USE MEASURES AMONG DISABLED MEDICARE BENEFICIARIES, 2011-2018
    Lewis, M.
    Zhou, L.
    Gellad, W. F.
    Hincapie-Castillo, J. M.
    Wilkie, D. J.
    Segal, R.
    Wilson, D. L.
    Lo-Ciganic, W. H.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S501 - S501
  • [6] Geographic variation of high-risk prescription opioid use measures among disabled medicare beneficiaries, 2011-2018
    Lewis, Motomori O.
    Zhou, Lili
    Gellad, Walid
    Hincapie-Castillo, Juan
    Wilkie, Diana
    Segal, Richard
    Wilson, Debbie
    Lo-Ciganic, Weihsuan Jenny
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 50 - 51
  • [7] Geographic variation of high-risk opioid use and risk of overdose among disabled medicare beneficiaries in the United States from 2011 to 2015
    Lo-Ciganic, Weihsuan
    Gellad, Walid
    Zhou, Lili
    Donohue, Julie
    Roubal, Anne
    Hines, Lisa
    Lindemann, Jeremiah
    Malone, Daniel
    Bhattacharjee, Sandipan
    Kwoh, C. Kent
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 374 - 374
  • [8] Geographic Variation in Use of Vestibular Testing among Medicare Beneficiaries
    Adams, Meredith E.
    Marmor, Schelomo
    Yueh, Bevan
    Kane, Robert L.
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2017, 156 (02) : 312 - 320
  • [9] Association of low-income subsidy, medicaid dual eligibility, and disability status with high-risk medication use among Medicare Part D beneficiaries
    Chinthammit, Chanadda
    Bhattacharjee, Sandipan
    Lo-Ciganic, Wei-Hsuan
    Axon, David R.
    Slack, Marion
    Bentley, John P.
    Warholak, Terri L.
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2022, 18 (04): : 2634 - 2642
  • [10] Geographic Variation in Diagnosis Frequency and Risk of Death Among Medicare Beneficiaries
    Welch, H. Gilbert
    Sharp, Sandra M.
    Gottlieb, Dan J.
    Skinner, Jonathan S.
    Wennberg, John E.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (11): : 1113 - 1118